Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT03673956
Eligibility Criteria:
Inclusion Criteria:
* Male or female, between 18-80 years old, diagnosed with chronic rhinosinusitis who have undergone previous functional endoscopic sinus surgery including at minimum maxillary antrostomy and anterior ethmoidectomy
* Active mucopurulence on endoscopic examination with corresponding culture demonstrating pathogenic bacterial growth
* Completion of written informed consent
* No prior enrollment into this study
* Refractory to maximal medical therapy
Exclusion Criteria:
* Patient has not had prior endoscopic sinus surgery consisting of at minimum maxillary antrostomy and anterior ethmoidectomy
* Patient is currently being treated with oral antibiotics
* Patient has been treated with oral or topical antibiotics within the past 14 days
* Participation in an investigational drug study simultaneously with participation in this study
* Concurrent use of oral steroids
* Allergy to Tobramycin, Mupirocin, Gentamicin and Levofloxacin
* Known to currently be pregnant
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT03673956
Study Brief:
Protocol Section:
NCT03673956